As reported in previous studies [10, 11, 16, 18], we confirmed that low GATA3 protein and mRNA associate with aggressive BC and add novel findings on GATA3‐related immuno‐metabolic alterations not previously reported. This evidence concerns the gene GATA3 and breast cancer.